Securities code: Xiamen Amoytop Biotech Co.Ltd(688278) securities abbreviation: Xiamen Amoytop Biotech Co.Ltd(688278) Announcement No.: 2022013 Xiamen Amoytop Biotech Co.Ltd(688278)
Announcement on the renewal of accounting firm
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
● name of the general accounting firm to be employed by Cheng Rong (special accounting firm)
1、 Basic information of the accounting firm to be renewed
(I) institutional information
1. Basic information
Rongcheng Certified Public Accountants (special general partnership) (hereinafter referred to as “Rongcheng certified public accountants”) was renamed from the former Huapu Tianjian Certified Public Accountants (special general partnership). It was initially established in August 1988 and restructured into a special general partnership on December 10, 2013. It is one of the earliest certified public accountants approved to engage in securities service business in China and has been engaged in securities service business for a long time. The registered address is 901-22 to 901-26, foreign economic and Trade Building 1, No. 22, Fuchengmenwai street, Xicheng District, Beijing, and the chief partner Xiao houfa.
As of December 31, 2021, Rongcheng accounting firm has 160 partners and 1131 certified public accountants, of which 504 have signed the audit report of securities service business.
The total audited revenue of Rongcheng certified public accountants in 2020 is 1875787300 yuan, including 16312632 million yuan from audit business and 7361092 million yuan from securities and futures business.
Rongcheng certified public accountants Co., Ltd. undertakes the annual report audit of 274 listed companies in 2020, with a total audit fee of 318433900 yuan. Its customers are mainly concentrated in manufacturing (including but not limited to computer, communication and other electronic equipment manufacturing, special equipment manufacturing, electrical machinery and equipment manufacturing, chemical raw materials and chemical products manufacturing, automobile manufacturing and pharmaceutical manufacturing), information transmission Software and information technology service industry, construction industry, wholesale and retail industry, water conservancy, environment and public facilities management industry, transportation, storage and postal industry, scientific research and technical service industry, financial industry, power, heat, gas and water production and supply industry, culture, sports and entertainment industry, mining industry and other industries. Rongcheng certified public accountants has 9 audit clients for listed companies in the same industry where Xiamen Amoytop Biotech Co.Ltd(688278) (hereinafter referred to as ” Xiamen Amoytop Biotech Co.Ltd(688278) ” or “the company”) is located.
2. Investor protection ability
Rongcheng certified public accountants has purchased professional liability insurance for certified public accountants, and the purchase of professional insurance complies with relevant regulations; As of December 31, 2021, the cumulative limit of liability and compensation is 900 million yuan.
Rongcheng certified public accountants has no relevant civil litigation and civil liability in the past three years. 3. Integrity record
Rongcheng certified public accountants has received 0 criminal punishment, 0 administrative punishment, 1 supervision and management measure, 1 self-discipline supervision measure and 0 disciplinary punishment for its practice in recent three years.
Five employees have been subject to self regulatory measures once due to their professional behavior during their practice in Rongcheng certified public accountants in recent three years; 11 employees have been supervised and managed once during their practice in Rongcheng certified public accountants in recent three years.
10 employees have been subject to supervision and management measures once each during their practice in other accounting firms in recent three years.
(II) project information
1. Basic information
Project partner: Zhang Lihe, who became a Chinese certified public accountant in 2000 and began to engage in the audit business of listed companies, began to practice in Rongcheng certified public accountants in 2019 and began to provide audit services for Xiamen Amoytop Biotech Co.Ltd(688278) in 2021; Audit reports of more than 10 listed companies have been signed or reviewed in the past three years.
Certified public accountant signing the project: Zheng Jiajing, who became a Chinese certified public accountant in 2019, began to engage in the audit business of Listed Companies in 2017, began to practice in Rongcheng certified public accountants in 2019, and began to provide audit services for Xiamen Amoytop Biotech Co.Ltd(688278) in 2021; Signed audit reports of Xiamen Amoytop Biotech Co.Ltd(688278) 1 listed company in recent three years.
Reviewer of project quality control: Zhu Dandan, who became a certified public accountant in 2010, began to engage in audit work in 2003 and began to practice in Rongcheng certified public accountants in 2020. He has signed or reviewed audit reports of many listed companies and has many years of experience in securities service business.
2. Integrity record
Zhang Lihe, the project partner, Zheng Jiajing, the signing certified public accountant and Zhu Dandan, the reviewer of project quality control, have not been subject to criminal punishment, administrative punishment, supervision and management measures, self-discipline supervision measures and disciplinary sanctions for their professional behavior in recent three years.
3. Independence
Rongcheng certified public accountants and the above personnel do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants.
4. Audit fees
(1) Audit fee pricing principle
The final audit fee shall be determined according to the company’s business scale, industry, complexity of accounting treatment and other factors, as well as the audit personnel and workload required for the audit of the company’s annual report, as well as the charging standard of the firm.
(2) Audit fees
In 2021, the financial audit fee of Rongcheng certified public accountants for the company was 795000 yuan (including tax), an increase of 7.14% over the previous period, of which the internal control audit fee was 80000 yuan. In 2022, the company will comprehensively consider the business scale, audit workload and other factors and negotiate with Rongcheng certified public accountants to determine the corresponding expenses.
2、 Procedures to be performed by the accounting firm to be reappointed
(I) performance of the audit committee
The second meeting of the audit committee of the eighth board of directors was held on March 30, 2022, and the proposal on renewing the appointment of accounting firm (3 votes in favor, 0 votes against and 0 abstention) was considered and adopted. The audit committee fully reviewed the professional ability, integrity and independence of Rongcheng accounting firm, and considered that Rongcheng accounting firm has many years of experience in financial audit and internal control audit services, With independent practice ability, professional competence, investor protection ability and good integrity record, he earnestly performed the responsibilities of the audit institution during his tenure as the audit institution of the company in 2021. The audit committee unanimously agreed to renew the appointment of Rongcheng certified public accountants as the company’s audit institution in 2022 for one year, and submitted the proposal to the board of directors for deliberation.
(II) prior approval opinions and independent opinions of independent directors
1. Prior approval opinions of independent directors: in combination with the audit of the company in 2021 and the verification of the professional qualification of Rongcheng certified public accountants and the resumes of project members, he was diligent and responsible during his tenure as the audit institution of the company in 2021, and was able to follow the professional standards of independence, objectivity and impartiality in the process of practice, and the report issued fairly reflected the financial status and operating results of the company, Agree to submit the proposal of renewing the appointment of the accounting firm to the board of directors for deliberation.
2. Independent opinion: Rongcheng certified public accountants has many years of audit service experience in listed companies and can meet the requirements of the company’s annual financial and internal control audit. The review and voting procedures of this renewed accounting firm comply with the provisions of relevant laws and regulations, and there is no damage to the interests of the company and the rights and interests of minority shareholders. It is agreed to continue to employ Rongcheng certified public accountants as the audit institution of the company in 2022 and submit the matter to the general meeting of shareholders for deliberation.
(III) deliberation and voting of the board of directors
The company held the 6th meeting of the 8th board of directors on March 30, 2022, deliberated and passed the proposal on renewing the appointment of accounting firm (9 votes in favor, 0 votes against and 0 abstention), agreed to continue to employ Rongcheng accounting firm as the audit institution of the company in 2022 for one year, and submitted the matter to the general meeting of shareholders for deliberation.
(IV) effective date
The renewal of the accounting firm needs to be submitted to the general meeting of shareholders of the company for deliberation and effective from the date of deliberation and approval by the general meeting of shareholders of the company.
It is hereby announced.
Xiamen Amoytop Biotech Co.Ltd(688278) board of directors
March 31, 2022
